Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension and renal dysfunction

P Zucchelli1, A Zuccalà

  • 1Malpighi Department of Nephrology, Bologna, Italy.

Current Opinion in Nephrology and Hypertension
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retroperitoneal approach for robot-assisted partial nephrectomy: technique and early outcomes.

International braz j urol : official journal of the Brazilian Society of Urology·2017
Same author

The ideal blood pressure target to prevent cardiovascular disease in type 2 diabetes: a neutral viewpoint.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2014
Same author

[Guidelines for management of hypertension: why doesn't evidence lead to unanimity?].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2009
Same author

[Refractory hypertention in a female patient with renal failure].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2005
Same author

Posterior tibial nerve stimulation: is the once-a-week protocol the best option?

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2005
Same author

[Hypertension, atherosclerosis and kidney].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2005
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026
See all related articles

Hypertension is a growing cause of kidney failure, but its link to progressive renal disease differs by race. Black patients may need aggressive treatment for unique kidney damage, while Caucasians often develop it later due to vascular issues.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Public Health

Background:

  • End-stage renal disease (ESRD) registries show rising hypertension as a cause of kidney failure.
  • The exact relationship between essential hypertension and progressive renal disease remains unclear.
  • Racial disparities exist in hypertension's impact on renal health.

Purpose of the Study:

  • To clarify the association between essential hypertension and progressive renal disease.
  • To investigate racial differences in hypertensive nephropathy.
  • To inform antihypertensive therapy strategies based on race.

Main Methods:

  • Retrospective analysis of ESRD registry data.
  • Comparative study of hypertensive nephropathy in Black and Caucasian populations.

Related Experiment Videos

  • Review of clinical characteristics and treatment responses.

    • Main Results:

    • Hypertension is a significant and increasing cause of ESRD.
    • Black hypertensive patients exhibit a distinct nephropathy, often leading to renal failure in middle age, potentially needing aggressive treatment.
    • Caucasian hypertensive patients typically develop renal disease later in life, linked to atheromatous renovascular disease.

    Conclusions:

    • Hypertensive nephropathy presents differently across racial groups.
    • Aggressive antihypertensive therapy may be crucial for Black patients with hypertension-induced renal disease.
    • True progressive hypertensive nephrosclerosis is uncommon in hypertensive patients.